Journals / Balkan Medical Journal / 2020 / Cilt: 37 - Sayı: 3

The Geographical Distribution of Morbidity Caused By Chronic Obstructive Pulmonary Disease in Turkey: COPDTURKEY-2

Pages
157–162
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The region with the highest prevalence of outpatientadmission and hospitalization was the Black Sea Region.Conclusion: The high rate of hospitalization was considered to be theoutcome of the insufficient “outpatient” management.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: Chronic obstructive pulmonary disease (COPD) is oneof the most prevalent causes for morbidity and mortality, and it createsa cumulative economic and social burden.Aims: To determine the distribution of the prevalence of patients inTurkey who were diagnosed with COPD and their morbidity rates,according to the regions and cities they belong to.
📊
Key Findings & Data:Moreover, the studycontributes to the prevention and cure services of COPD that shouldbe planned in the future.Study Design: A retrospective cohort.Methods: The database of the Social Security Institution from 2016has been scanned.
💡
Conclusion & Impact:The region with the highest prevalence of outpatientadmission and hospitalization was the Black Sea Region.Conclusion: The high rate of hospitalization was considered to be theoutcome of the insufficient “outpatient” management.
🔬Design:Research Article
📍Scope:2016 Verileri
⚙️Variables:Domain Parameters

Abstract

Background: Chronic obstructive pulmonary disease (COPD) is oneof the most prevalent causes for morbidity and mortality, and it createsa cumulative economic and social burden.Aims: To determine the distribution of the prevalence of patients inTurkey who were diagnosed with COPD and their morbidity rates,according to the regions and cities they belong to. Moreover, the studycontributes to the prevention and cure services of COPD that shouldbe planned in the future.Study Design: A retrospective cohort.Methods: The database of the Social Security Institution from 2016has been scanned. All the data with prescription registration, with thecode ICD-10, J44.0-J44.9, which were aimed for diagnosing and/orcure, have been evaluated with a retrospective cohort.Results: In 2016, 955,369 patients who were admitted as outpatientsto the hospitals were diagnosed with COPD. The average number ofannual COPD cases that were admitted was 2.09. Twenty percent(20%) of the outpatient applications were via emergency room. Therate of hospitalization among the applicants was 17.75%, with a totalof 1,994,325. The average annual number of hospitalizations of menwas higher than that of women. The average number of hospitalizationdays was 6.52. The region with the highest prevalence of outpatientadmission and hospitalization was the Black Sea Region.Conclusion: The high rate of hospitalization was considered to be theoutcome of the insufficient “outpatient” management.

🔖

Cite This Article

ÖZTÜRK, C., ÖZDEMİR, T., KOÇ, O., ÖZDİLEKCAN, Ç., KILIÇ, H., HASANOĞLU, H. C., TÜRKKANI, M. H., DEMİRCİ, N. Y. (2022). The Geographical Distribution of Morbidity Caused By Chronic Obstructive Pulmonary Disease in Turkey: COPDTURKEY-2. Balkan Medical Journal, Cilt: 37 - Sayı: 3, 157–162. https://ajindex.com/articles/460900

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J2006;27:397- 412
  2. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med2006;3:442
  3. López-Campos JL, Tan W, Soriano JB. Global burden of COPD.Respirology. 2016;21:14-23
  4. Chapman KR, Mannino DM, Soriano JB, Vermeire PA, Buist AS, Thun MJ, et al. Epidemiology and cost of chronic obstructive pulmonary disease. Eur Respir J2006;27:188-207
  5. Global Strategy for The Diagnosis, Management, And Prevention of Chronic Obstructive Pulmonary Disease (2016 Report), Global Initiative for Chronic Obstructive Lung Disease (GOLD),2019
  6. Kronik Obstrüktif Akciğer Hastalığı (KOAH) Koruma, Tanı ve Tedavi Raporu, Türk Toraks Derneği KOAH Çalışma Grubu; 2014
  7. Rennard S, Decramer M, Calverley PM, Pride NB, Soriano JB, Vermeire PA, et al. Impact of COPD in North America and Europe in 2000: subjects’ perspective of Confronting COPD International Survey. Eur Respir J 2002;20:799-805
  8. Viegi G, Scognamiglio A, Baldacci S, Pistelli F, Carrozzi L. Epidemiology of chronic obstructive pulmonary disease (COPD). Respiration 2001;68:4-19
  9. Türkiye Kronik Hava Yolu Hastalıkları Önleme ve Kontrol Programı (2014-2017), T.C. Sağlık Bakanlığı Türkiye Halk Sağlığı Kurumu, Sağlık Bakanlığı Yayın No:947, Ankara; 2014
  10. Türkiye Hastalık Yükü Çalışması 2004, T.C. Sağlık Bakanlığı, Refik Saydam Hıfzıssıhha Merkezi Başkanlığı, Hıfzıssıhha Mektebi Müdürlüğü, Sağlık Bakanlığı Yayın No: 701, Ankara, 2006. 11.
  11. Souliotis K, Kani C, Papageorgiou M, Lionis D, Gourgoulianis K. Using Big Data to Assess Prescribing Patterns in Greece: The Case of Chronic Obstructive Pulmonary Disease. PLoS One 2016;11:e0154960
  12. Johansson G, Mushnikov V, Bäckström T, Engström A, Khalid JM, Wall J, et al. Exacerbations and health care resource utilization among COPD patients in a Swedish registry-based nation-wide study. BMC Pulm Med 2018;18:17
  13. LamprechtB,McBurnieMA,VollmerWM,Gudmundsson G, Welte T, NizankowskaMogilnicka E, etal.COPD in never smokers: results from the population-based burden of obstructive lung disease study. Chest 2011;139:752-63
  14. Türkiye’de Tütün Kullanım Oranları, TürkiyeSağlıkAraştırması, 2016, Türkiye İstatistik Kurumu Haber Bülteni, Sayı: 24573, 31 Mayıs2017
  15. SağlıkİstatistikleriYıllığı 2016, TC Sağlık Bakanlığı Sağlık